There's a new cancer development that is in clinical trials. It was developed by Dr. Stanislaw Burzynski and uses antineoplastons which is a naturally occurring substance that alters the genetics of the cancer cells.
Preliminary results from six brain tumor studies gave a combined overall response rate of from 68% to 88%. For information, call the Burzynski Clinic in Houston at (281) 597-0111
No comments:
Post a Comment